BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37210313)

  • 21. Treatment of renal cell carcinoma with a level III or level IV inferior vena cava thrombus using cardiopulmonary bypass and deep hypothermic circulatory arrest.
    Chen YH; Wu XR; Hu ZL; Wang WJ; Jiang C; Kong W; Chen W; Xue W; Liu DM; Huang YR
    World J Surg Oncol; 2015 Apr; 13():159. PubMed ID: 25897659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
    Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
    Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor?
    Choi DK; Jeon HG; Jeong CW; Kwak C; Song C; Chung J; Hong SK; Hong SH; Seo SI;
    Int J Urol; 2017 Feb; 24(2):102-109. PubMed ID: 28111837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are markers of survival associated with perioperative outcomes for tumor thrombectomy patients?
    Fang AM; Leahy S; Saidian A; Oster RA; Nix JW; Sudarshan S; Rais-Bahrami S; Peyton CC
    Urol Oncol; 2023 Aug; 41(8):358.e17-358.e24. PubMed ID: 37301680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of venous tumor thrombus combined with bland thrombus on the surgical treatment and prognosis of renal cell carcinoma patients.
    Liu Z; Zhang L; Hong P; Li L; Tang S; Zhao X; Zhang Q; Zhu G; Peng R; Wang B; Chen Z; Sun Z; Yang F; Wang G; Tian X; Zhang S; Huang Y; Zhang H; Liu C; Wang S; Ma L
    Cancer Med; 2020 Aug; 9(16):5860-5868. PubMed ID: 32627973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.
    Yang B; Xia H; Xu C; Lu M; Zhang S; Wang G; Ma L
    BMC Urol; 2020 Feb; 20(1):14. PubMed ID: 32070319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors of recurrence after surgery in patients with non-metastatic renal cell carcinoma with venous tumor thrombus (UroCCR-56 Study).
    Baboudjian M; Gondran-Tellier B; Khene Z; Bigot P; Mejean A; Lang H; Lebacle C; Doumerc N; Bruyere F; Nouhaud FX; Ouzaid I; Bensalah K; Bernhard JC; Boissier R
    World J Urol; 2023 Feb; 41(2):295-302. PubMed ID: 33765164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava.
    Spachmann PJ; Breyer J; Kalogirou C; Lausenmeyer EM; Weber F; Prohaska S; Denzinger S; Burger M; Kübler H; Otto W; Vergho D
    Urol Int; 2019; 102(4):413-420. PubMed ID: 30844790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer.
    Psutka SP; Boorjian SA; Moynagh MR; Schmit GD; Costello BA; Thompson RH; Stewart-Merrill SB; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK
    J Urol; 2016 Feb; 195(2):270-6. PubMed ID: 26292038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Khan AI; Psutka SP; Patil DH; Hong G; Williams MA; Bilen MA; Sekhar A; Kissick HT; Narayan VM; Joshi SS; Ogan K; Master VA
    Cancer; 2022 Jun; 128(11):2073-2084. PubMed ID: 35285950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience.
    Abel EJ; Thompson RH; Margulis V; Heckman JE; Merril MM; Darwish OM; Krabbe LM; Boorjian SA; Leibovich BC; Wood CG
    Eur Urol; 2014 Sep; 66(3):584-92. PubMed ID: 24262104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging predictors for assessment of inferior vena cava wall invasion in patients with renal cell carcinoma and inferior vena cava tumor thrombus: a retrospective study.
    Wang BS; Li YZ; Fang YY; Zhang SD; Ma LL
    Chin Med J (Engl); 2020 Sep; 133(17):2078-2083. PubMed ID: 32898352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of deep invasive tumor thrombus on the surgical treatment and prognosis of patients with non-metastatic renal cell carcinoma complicated with venous tumor thrombus].
    Zhao X; Yan Y; Huang XJ; Dong JH; Liu Z; Zhang HX; Liu C; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):665-670. PubMed ID: 34393225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC).
    Weiss VL; Braun M; Perner S; Harz A; Vorreuther R; Kristiansen G; Müller SC; Ellinger J
    BJU Int; 2014 Feb; 113(2):209-17. PubMed ID: 24053185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal cell carcinoma with tumor thrombus growing against the direction of venous return: an indicator of complicated surgery and poor prognosis.
    Liu Z; Li Y; Zhao X; Ge L; Zhu G; Hong P; Tang S; Zhang S; Tian X; Wang S; Liu C; Zhang H; Ma L
    BMC Surg; 2021 Dec; 21(1):443. PubMed ID: 34963464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus.
    Kaplan S; Ekici S; Doğan R; Demircin M; Ozen H; Paşaoğlu I
    Am J Surg; 2002 Mar; 183(3):292-9. PubMed ID: 11943130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombus.
    Ishiyama Y; Kondo T; Tachibana H; Ishihara H; Yoshida K; Takagi T; Iizuka J; Tanabe K
    Urol Oncol; 2022 Mar; 40(3):110.e11-110.e18. PubMed ID: 35027262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
    Schmeusser BN; Biermann H; Nicaise EH; Ali AA; Patil DH; Midenberg E; Helman T; Armas-Phan M; Nabavizadeh R; Joshi SS; Narayan VM; Bilen MA; Psutka SP; Ogan K; Master VA
    Oncologist; 2023 Dec; 28(12):e1219-e1229. PubMed ID: 37540787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.
    Cho MC; Kim JK; Moon KC; Kim HH; Kwak C
    Int Braz J Urol; 2013; 39(3):353-63. PubMed ID: 23849567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.